Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2868)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Treatment of Complementary and Alternative Medicine on Premature Ovarian Failure. (2021/04/15) ♡
- KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1. (2021/04/15) ♡
- Supramolecular self-associating amphiphiles (SSAs) as nanoscale enhancers of cisplatin anticancer activity. (2021/04/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer. (2021/04/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrition in Gynecological Diseases: Current Perspectives. (2021/04/02) ♡
- Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. (2021/04/01) ♡
- Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. (2021/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Ovarian cancer risk according to circulating zinc and copper concentrations: A meta-analysis and Mendelian randomization study. (2021/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Diet and ovarian cancer risk: An umbrella review of systematic reviews and meta-analyses of cohort studies. (2021/04/01) ♡
- Two SPRi biosensors for the determination of cathepsin S in blood plasma. (2021/04/01) ♡
- Folic acid functionalized gold nanoclusters for enabling targeted fluorescence imaging of human ovarian cancer cells. (2021/04/01) ♡
- Epigenetic Silencing of DAPK1and p16 (INK4a) Genes by CpG Island Hypermethylation in Epithelial Ovarian Cancer Patients. (2021/04/01) ♡
- Hyperinsulinemia and Hypoadiponectinemia are Associated with Increased Risk for Occurrence of Ovarian Cancer in Non-diabetic Women of North Indian Population. (2021/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z(HER2)-Idarubicin Conjugate: An in vitro Study. (2021/04/01) ♡
- Genetic Counseling Clinic at AIIMS (New Delhi). (2021/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers. (2021/04/01) ♡
- TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer. (2021/04/01) ♡
- Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes. (2021/03/31) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Aidi injection, a traditional Chinese biomedical preparation for gynecologic tumors: a systematic review and PRISMA-compliant meta-analysis. (2021/03/26) ♡
- Analysing culture methods of frozen human ovarian tissue to improve follicle survival. (2021/03/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer. (2021/03/11) ♡
- Ketamine Inhibits Ovarian Cancer Cell Growth by Regulating the lncRNA-PVT1/EZH2/p57 Axis. (2021/03/08) ♡
- Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients. (2021/03/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic Implications of a Polymethoxylated Flavone, Tangeretin, in the Management of Cancer via Modulation of Different Molecular Pathways. (2021/03/05) ♡
- Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma. (2021/03/01) ♡
- Posttraumatic Stress Disorder and Likelihood of Hormone Therapy Use among Women in the Nurses' Health Study II: A 26-Year Prospective Analysis. (2021/03/01) ♡
- Biological Impact of Unilateral Oophorectomy: Does the Number of Ovaries Really Matter? (2021/03/01) ♡
- Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute. (2021/03/01) ♡
- Effects of epigallocatechin gallate, epigallocatechin and epicatechin gallate on the chemical and cell-based antioxidant activity, sensory properties, and cytotoxicity of a catechin-free model beverage. (2021/03/01) ♡
- Ganoderma tsugae suppresses the proliferation of endometrial carcinoma cells via Akt signaling pathway. (2021/03/01) ♡
- The effect of different concentrations of cerium oxide during pregnancy on ovarian follicle development in neonatal mice. (2021/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic strategies to overcome taxane resistance in cancer. (2021/03/01) ♡
- Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma. (2021/03/01) ♡
- EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer. (2021/02/25) ♡
- TOX3 Promotes Ovarian Estrogen Synthesis: An RNA-Sequencing and Network Study. (2021/02/24) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis. (2021/02/22) ♡
- Multiple U-Net-Based Automatic Segmentations and Radiomics Feature Stability on Ultrasound Images for Patients With Ovarian Cancer. (2021/02/18) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo. (2021/02/17) ♡
- Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer. (2021/02/17) ♡
- Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network. (2021/02/16) ♡
- Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. (2021/02/15) ♡
- SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer. (2021/02/15) ♡
- Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study. (2021/02/12) ♡
- Endothelin-1 Exhibiting Pro-Nociceptive and Pro-Peristaltic Activities Is Increased in Peritoneal Carcinomatosis. (2021/02/11) ♡
- Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort. (2021/02/10) ♡
- Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy. (2021/02/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Paradoxical Behavior of microRNA-211 in Melanomas and Other Human Cancers. (2021/02/08) ♡
- Long Non-coding RNA LINC01969 Promotes Ovarian Cancer by Regulating the miR-144-5p/LARP1 Axis as a Competing Endogenous RNA. (2021/02/04) ♡
- Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates. (2021/02/03) ♡
- Osthole interacts with an ER-mitochondria axis and facilitates tumor suppression in ovarian cancer. (2021/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.